We further assessed CYGB expression in hPDAC tissue from 157 patients, including 8, 24, 120, and 5 patients classified as Stage T1, T2, T3, and T4, respectively, as assessed using the tumor-node-metastasis pancreatic tumor classification system described in the 8th edition of the Union for International Cancer Control staging system (Supplemental Table 1). This evidence concerns the gene CYGB and pancreatic neoplasm.